Author： Dillner J.
Publisher： Academic Press
ISSN： 1044-579X
Source： Seminars in Cancer Biology, Vol.9, Iss.6, 1999-12, pp. : 423-430
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
The antibody response to papillomaviruses is a key determinant of protective immunity. HPV serology is also an important epidemiological tool for the assay of past and present HPV infections and for prediction of HPV-associated cancers and their precursor lesions. This review focuses on the assay of antibody responses to the HPV capsid, its use as a marker of cumulative HPV exposure and surveys how HPV seroepidemiology has been used to elucidate the spread of HPV infection in various populations, the natural history of HPV infection and that exposure to HPV is associated with increased risk for several human cancers.
Related content
Heterogeneity of papillomaviruses
By Myers G. Lu H. Calef C. Leitner T.
Seminars in Cancer Biology, Vol. 7, Iss. 6, 1996-12 ,pp. :
Access to resources
Recommend
By Nordøy Tone Aaberge Ingeborg Husebekk Anne Samdal Helvi Steinert Svein Melby Hasse Kolstad Arne
Medical Oncology, Vol. 19, Iss. 2, 2002-06 ,pp. :
The role of human papillomaviruses in anogenital cancers
Seminars in Cancer Biology, Vol. 8, Iss. 4, 1997-08 ,pp. :
The interaction between p53 and papillomaviruses
Seminars in Cancer Biology, Vol. 9, Iss. 6, 1999-12 ,pp. :
The Role of Human Papillomaviruses in Cancer: Evidence to Date
American Journal of Cancer, Vol. 4, Iss. 1, 2005-01 ,pp. :